共 312 条
- [1] Elbaz A(2016)Epidemiology of Parkinson’s disease Rev Neurol (Paris) 172 14-26
- [2] Carcaillon L(2004)Dementia with Lewy bodies Lancet Neurol 3 19-28
- [3] Kab S(2007)Dementia with Lewy bodies Neurol Clin 25 741-747
- [4] Moisan F(2005)A systematic review of prevalence and incidence studies of dementia with Lewy bodies Age Ageing 34 561-566
- [5] McKeith I(1987)Radiochemistry, biochemistry, and kinetics of 131I-metaiodobenzylguanidine (MIBG) and 123I-MIBG: clinical implications of the use of 123I-MIBG Med Pediatric Oncol 15 170-177
- [6] Mintzer J(2015)Impact of medications on mIBG uptake, with specific attention to the heart: comprehensive review of the literature J Nucl Cardiol 22 980-993
- [7] Aarsland D(2010)Proposal for standardization of 123I-metaiodobenzylguanidine (MIBG) cardiac sympathetic imaging by the EANM Cardiovascular Committee and the European Council of Nuclear Cardiology Eur J Nucl Med Mol Imaging 37 1802-1812
- [8] Burn D(1998)Differentiation of idiopathic Parkinson’s disease from striatonigral degeneration and progressive supranuclear palsy using iodine-123 meta-iodobenzylguanidine myocardial scintigraphy J Neurol Sci 155 60-67
- [9] Chiu H(1999)123I-metaiodobenzylguanidine myocardial scintigraphy in Parkinson’s disease J Neurol Neurosurg Psychiatry 67 189-194
- [10] Cohen-Mansfield J(2001)Assessment of underlying etiology and cardiac sympathetic innervation to identify patients at high risk of cardiac events J Nucl Med 42 1757-1767